Health
Immunity developed by SARS-CoV-2 infection can protect against E484K variants, suggests study – News-Medical.Net
A team of scientists from Japan has recently investigated the neutralizing potency of convalescent sera against currently circulating SARS-CoV-2 variants with multiple…
A team of scientists from Japan has recently investigated the neutralizing potency of convalescent sera against currently circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with multiple spike mutations.
The study’s findings reveal that the variants containing Y543F or N501Y spike mutations are capable of evading neutralization by SARS-CoV-2-induced antibodies. However, no such immune evading potency has been observed for the variants with only the E484K spike mutation.
…
-
Business19 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
General24 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands
-
Noosa News21 hours agoQueenslanders to continue legal challenges against COVID-19 directives after successful appeal
-
Noosa News14 hours agoRacing Queensland responds to criticism of ‘deadliest’ greyhound track